Lead sponsor

The University of Texas Medical Branch, Galveston

1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

1

Trials led

1

Active

90

Total enrollment

1

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 2
1

Trials by status

Recruiting
1

Trials led

Tirzepatide to Slow Biological AgingBMI ≥30Ph 2Recruiting90